A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Clinical trial NCT05563766 · RECRUITING

Trial details

NCT number: NCT05563766
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Esophageal Squamous Cell Carcinoma Gastroesophageal Junction Carcinoma

Start date: 2024-10-01
Primary completion: 2029-04-30
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.